Folate Therapy Improves the Stress-To-Rest Mean Lv Volume Ratio in Myocardial Perfusion Imaging in Patients With Diabetes Publisher Pubmed



Emamiardekani A¹ ; Esteghamati A² ; Farzanefar S³ ; Abousaidi M¹ ; Abbasi M³ ; Abdollahi S¹ ; Fallahi B¹ ; Beiki D¹ ; Fardesfahani A¹ ; Nakhjavani M² ; Eftekhari M¹ Show Affiliations
Source: Annals of Nuclear Medicine Published:2015

Abstract

Objective: Patients with diabetes have higher stress-to-rest mean left ventricular volume (SRLVV) ratio in myocardial perfusion imaging (MPI) and hyperhomocysteinemia. We studied the effect of folate therapy on SRLVV ratio and plasma homocysteine levels in patients with diabetes. Methods: Forty patients were enrolled and thirty-two completed the study. The patients underwent a 2-day pharmacological stress test and rest MPI before and 2 months after treatment with either 5 mg folic acid or placebo. SRLVV ratios were calculated, and plasma homocysteine levels were measured, before and after treatment. Results: Among the 32 patients who completed the study, 15 received folic acid and 17 received placebo. The age of subjects (folate 51.5 ± 6.1 years; placebo 50.6 ± 8.1 years), male/female ratio (folate 6/11; placebo 9/6),or MPI findings (proportion of normal results: folate 80.0 %; placebo 94.1 %) were similar between the two groups. The baseline SRLVV ratio was similar between groups (folate: 1.00 ± 0.09 vs. placebo: 0.97 ± 0.13); however, the post-treatment SRLVV ratio was significantly lower (P < 0.001) in the folate group than in the placebo group (folate: 0.93 ± 0.10 vs. placebo: 1.04 ± 0.17). A general linear repeated-measures model showed a significant difference in the change in SRLVV ratio between participants receiving folate and those receiving placebo. Post-treatment homocysteine level was lower after folate treatment (from 14.5 ± 4.6 to 11.5 ± 5.3 µmol/L), as compared to placebo (from 13.7 ± 5.0 to 17.9 ± 4.5 µmol/L) (P = 0.01). The changes in SRLVV ratio and homocysteine level were correlated (r = 0.45; P = 0.016). Conclusions: Short-term folate therapy reduced SRLVV ratio and plasma homocysteine level. © 2015, The Japanese Society of Nuclear Medicine.